-
1
-
-
0028921573
-
Jaks and Stats in signaling by the cytokine receptor superfamily
-
Ihle JN Kerr IM. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 1995 11 69 74.
-
(1995)
Trends Genet
, vol.11
, pp. 69-74
-
-
Ihle, J.N.1
Kerr, I.M.2
-
2
-
-
0029069145
-
Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
-
Schindler C Darnell JE Jr.. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995 64 621 51.
-
(1995)
Annu Rev Biochem
, vol.64
, pp. 621-51
-
-
Schindler, C.1
Darnell Jr., J.E.2
-
3
-
-
0036233585
-
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway
-
O'Shea JJ Gadina M Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002 109 Suppl. S121 31.
-
(2002)
Cell
, vol.109
, Issue.SUPPL.
, pp. 121-31
-
-
O'Shea, J.J.1
Gadina, M.2
Schreiber, R.D.3
-
4
-
-
0026770248
-
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
-
Schindler C Shuai K Prezioso VR Darnell JE Jr.. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992 257 809 13.
-
(1992)
Science
, vol.257
, pp. 809-13
-
-
Schindler, C.1
Shuai, K.2
Prezioso, V.R.3
Darnell Jr., J.E.4
-
6
-
-
0031443156
-
Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
-
Garcia R Yu CL Hudnall A et al. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 1997 8 1267 76.
-
(1997)
Cell Growth Differ
, vol.8
, pp. 1267-76
-
-
Garcia, R.1
Yu, C.L.2
Hudnall, A.3
-
7
-
-
0035799531
-
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
-
Garcia R Bowman TL Niu G et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001 20 2499 513.
-
(2001)
Oncogene
, vol.20
, pp. 2499-513
-
-
Garcia, R.1
Bowman, T.L.2
Niu, G.3
-
8
-
-
0032984589
-
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
-
Catlett-Falcone R Landowski TH Oshiro MM et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999 10 105 15.
-
(1999)
Immunity
, vol.10
, pp. 105-15
-
-
Catlett-Falcone, R.1
Landowski, T.H.2
Oshiro, M.M.3
-
9
-
-
0013689209
-
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
-
Grandis JR Drenning SD Chakraborty A et al. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest 1998 102 1385 92.
-
(1998)
J Clin Invest
, vol.102
, pp. 1385-92
-
-
Grandis, J.R.1
Drenning, S.D.2
Chakraborty, A.3
-
10
-
-
0034658499
-
STAT signaling in head and neck cancer
-
Song JI Grandis JR. STAT signaling in head and neck cancer. Oncogene 2000 19 2489 95.
-
(2000)
Oncogene
, vol.19
, pp. 2489-95
-
-
Song, J.I.1
Grandis, J.R.2
-
11
-
-
0032852374
-
ErbB-2 kinase is required for constitutive Stat3 activation in malignant human lung epithelial cells
-
Fernandes A Hamburger AW Gerwin BI. ErbB-2 kinase is required for constitutive Stat3 activation in malignant human lung epithelial cells. Int J Cancer 1999 83 564 70.
-
(1999)
Int J Cancer
, vol.83
, pp. 564-70
-
-
Fernandes, A.1
Hamburger, A.W.2
Gerwin, B.I.3
-
12
-
-
0034163461
-
Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells
-
Ni Z Lou W Leman ES Gao AC. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res 2000 60 1225 8.
-
(2000)
Cancer Res
, vol.60
, pp. 1225-8
-
-
Ni, Z.1
Lou, W.2
Leman, E.S.3
Gao, A.C.4
-
13
-
-
85047698100
-
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
-
Burke WM Jin X Lin HJ et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001 20 7925 34.
-
(2001)
Oncogene
, vol.20
, pp. 7925-34
-
-
Burke, W.M.1
Jin, X.2
Lin, H.J.3
-
14
-
-
2542538216
-
Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes
-
Quadros MR Peruzzi F Kari C Rodeck U. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes. Cancer Res 2004 64 3934 9.
-
(2004)
Cancer Res
, vol.64
, pp. 3934-9
-
-
Quadros, M.R.1
Peruzzi, F.2
Kari, C.3
Rodeck, U.4
-
15
-
-
1942538505
-
Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis
-
Chan KS Carbajal S Kiguchi K et al. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res 2004 64 2382 9.
-
(2004)
Cancer Res
, vol.64
, pp. 2382-9
-
-
Chan, K.S.1
Carbajal, S.2
Kiguchi, K.3
-
16
-
-
4944239032
-
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis
-
Chan KS Sano S Kiguchi K et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004 114 720 8.
-
(2004)
J Clin Invest
, vol.114
, pp. 720-8
-
-
Chan, K.S.1
Sano, S.2
Kiguchi, K.3
-
17
-
-
1042302005
-
The STATs of cancer - New molecular targets come of age
-
Yu H Jove R. The STATs of cancer - new molecular targets come of age. Natl Rev Cancer 2004 4 97 105.
-
(2004)
Natl Rev Cancer
, vol.4
, pp. 97-105
-
-
Yu, H.1
Jove, R.2
-
18
-
-
0037096876
-
Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma
-
Masuda M Suzui M Yasumatu R et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 2002 62 3351 5.
-
(2002)
Cancer Res
, vol.62
, pp. 3351-5
-
-
Masuda, M.1
Suzui, M.2
Yasumatu, R.3
-
19
-
-
0033774437
-
Mammary and extramammary Paget's disease
-
Lloyd J Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000 53 742 9.
-
(2000)
J Clin Pathol
, vol.53
, pp. 742-9
-
-
Lloyd, J.1
Flanagan, A.M.2
-
20
-
-
0033999297
-
The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease
-
Ohnishi T Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol 2000 142 243 7.
-
(2000)
Br J Dermatol
, vol.142
, pp. 243-7
-
-
Ohnishi, T.1
Watanabe, S.2
-
22
-
-
0034547753
-
Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells
-
Cataldo L Chen NY Yuan Q et al. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells. Int J Oncol 2000 17 1179 85.
-
(2000)
Int J Oncol
, vol.17
, pp. 1179-85
-
-
Cataldo, L.1
Chen, N.Y.2
Yuan, Q.3
-
23
-
-
4944250270
-
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy
-
Selander KS Li L Watson L et al. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res 2004 64 6924 33.
-
(2004)
Cancer Res
, vol.64
, pp. 6924-33
-
-
Selander, K.S.1
Li, L.2
Watson, L.3
-
24
-
-
0037386568
-
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
-
Leong PL Andrews GA Johnson DE et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci USA 2003 100 4138 43.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 4138-43
-
-
Leong, P.L.1
Andrews, G.A.2
Johnson, D.E.3
-
25
-
-
2442663092
-
Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility
-
Silver DL Naora H Liu J et al. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004 64 3550 8.
-
(2004)
Cancer Res
, vol.64
, pp. 3550-8
-
-
Silver, D.L.1
Naora, H.2
Liu, J.3
-
26
-
-
0036075424
-
Activation of signal transduction and activator of transcription 3 in renal cell carcinoma: A study of incidence and its association with pathological features and clinical outcome
-
Horiguchi A Oya M Shimada T et al. Activation of signal transduction and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 2002 168 762 5.
-
(2002)
J Urol
, vol.168
, pp. 762-5
-
-
Horiguchi, A.1
Oya, M.2
Shimada, T.3
-
27
-
-
0037461934
-
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
-
Wei D Le X Zheng L et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003 22 319 29.
-
(2003)
Oncogene
, vol.22
, pp. 319-29
-
-
Wei, D.1
Le, X.2
Zheng, L.3
-
28
-
-
85047695527
-
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
-
Niu G Wright KL Huang M et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002 21 2000 8.
-
(2002)
Oncogene
, vol.21
, pp. 2000-8
-
-
Niu, G.1
Wright, K.L.2
Huang, M.3
-
29
-
-
2442685645
-
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis
-
Xie TX Wei D Liu M et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004 23 3550 60.
-
(2004)
Oncogene
, vol.23
, pp. 3550-60
-
-
Xie, T.X.1
Wei, D.2
Liu, M.3
-
30
-
-
0034676267
-
Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: Role of activated STAT3 signaling
-
Sinibaldi D Wharton W Turkson J et al. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 2000 19 5419 27.
-
(2000)
Oncogene
, vol.19
, pp. 5419-27
-
-
Sinibaldi, D.1
Wharton, W.2
Turkson, J.3
-
31
-
-
0034953532
-
Molecular markers in Paget disease of the breast
-
Fu W Lobocki CA Silberberg BK et al. Molecular markers in Paget disease of the breast. J Surg Oncol 2001 77 171 8.
-
(2001)
J Surg Oncol
, vol.77
, pp. 171-8
-
-
Fu, W.1
Lobocki, C.A.2
Silberberg, B.K.3
-
32
-
-
0028836031
-
Chromosome 11q13 markers and D-type cyclins in breast cancer
-
Peters G Fantl V Smith R et al. Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 1995 33 125 35.
-
(1995)
Breast Cancer Res Treat
, vol.33
, pp. 125-35
-
-
Peters, G.1
Fantl, V.2
Smith, R.3
-
33
-
-
0027938209
-
Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
-
Hunter T Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 1994 79 573 82.
-
(1994)
Cell
, vol.79
, pp. 573-82
-
-
Hunter, T.1
Pines, J.2
-
34
-
-
0026526437
-
E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
-
Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992 258 424 9.
-
(1992)
Science
, vol.258
, pp. 424-9
-
-
Nevins, J.R.1
-
35
-
-
0027282044
-
Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
-
Boise LH Gonzalez-Garcia M Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993 74 597 608.
-
(1993)
Cell
, vol.74
, pp. 597-608
-
-
Boise, L.H.1
Gonzalez-Garcia, M.2
Postema, C.E.3
-
36
-
-
0027441586
-
Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level
-
Wegenka UM Buschmann J Lutticken C et al. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993 13 276 88.
-
(1993)
Mol Cell Biol
, vol.13
, pp. 276-88
-
-
Wegenka, U.M.1
Buschmann, J.2
Lutticken, C.3
-
37
-
-
0033781642
-
Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells
-
Huang M Page C Reynolds RK Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000 79 67 73.
-
(2000)
Gynecol Oncol
, vol.79
, pp. 67-73
-
-
Huang, M.1
Page, C.2
Reynolds, R.K.3
Lin, J.4
|